Correlation Between Replimune and Biomarin Pharmaceutical
Can any of the company-specific risk be diversified away by investing in both Replimune and Biomarin Pharmaceutical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Replimune and Biomarin Pharmaceutical into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Replimune Group and Biomarin Pharmaceutical, you can compare the effects of market volatilities on Replimune and Biomarin Pharmaceutical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Replimune with a short position of Biomarin Pharmaceutical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Replimune and Biomarin Pharmaceutical.
Diversification Opportunities for Replimune and Biomarin Pharmaceutical
0.19 | Correlation Coefficient |
Average diversification
The 3 months correlation between Replimune and Biomarin is 0.19. Overlapping area represents the amount of risk that can be diversified away by holding Replimune Group and Biomarin Pharmaceutical in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Biomarin Pharmaceutical and Replimune is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Replimune Group are associated (or correlated) with Biomarin Pharmaceutical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Biomarin Pharmaceutical has no effect on the direction of Replimune i.e., Replimune and Biomarin Pharmaceutical go up and down completely randomly.
Pair Corralation between Replimune and Biomarin Pharmaceutical
Given the investment horizon of 90 days Replimune Group is expected to under-perform the Biomarin Pharmaceutical. In addition to that, Replimune is 1.62 times more volatile than Biomarin Pharmaceutical. It trades about -0.12 of its total potential returns per unit of risk. Biomarin Pharmaceutical is currently generating about 0.22 per unit of volatility. If you would invest 6,325 in Biomarin Pharmaceutical on November 29, 2024 and sell it today you would earn a total of 556.00 from holding Biomarin Pharmaceutical or generate 8.79% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 95.45% |
| Values | Daily Returns |
Replimune Group vs. Biomarin Pharmaceutical
Performance |
| Timeline |
| Replimune Group |
| Biomarin Pharmaceutical |
Replimune and Biomarin Pharmaceutical Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Replimune and Biomarin Pharmaceutical
The main advantage of trading using opposite Replimune and Biomarin Pharmaceutical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Replimune position performs unexpectedly, Biomarin Pharmaceutical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biomarin Pharmaceutical will offset losses from the drop in Biomarin Pharmaceutical's long position.| Replimune vs. Nuvalent | Replimune vs. Ventyx Biosciences | Replimune vs. Ascendis Pharma AS | Replimune vs. United Therapeutics |
| Biomarin Pharmaceutical vs. Alnylam Pharmaceuticals | Biomarin Pharmaceutical vs. Exelixis | Biomarin Pharmaceutical vs. Halozyme Therapeutics | Biomarin Pharmaceutical vs. Arrowhead Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Other Complementary Tools
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios |